Some of the bleeding tendency in patients with Type 3 VWD (<1% VWF activity) and Type 2N (Normandy) VWD (in which the mutation in VWF results in defective binding and stabilisation of FVIII) is accounted for by FVIII deficiency [87]. The gene discussed is F8; the disease is von Willebrand disease (hereditary or acquired).